Methocarbamol liquid 100mg/ml, RX, glass vial

FDA recall notice · announced January 9, 2019 · Hiers Enterprises, Llc Dba Northwest Compounding Pharmacy

Class II FDA/FSIS Class II: use may cause temporary or medically reversible adverse health consequences.

The product

Reason for recall

Lack of sterility assurance.

Notes

Distribution: Product was distributed exclusively in the state of Oregon to 3 Medical facilities, 1 Physician's office and 80 consumers/patients. These are compounded products - labels vary for each compound - specific to each patient. Firm did not provide labeling.
Lot/code information: 10082018@34 exp 1/6/19, 10312018@27 exp 1/29/19
Quantity: 300 ml
Status: Terminated
Products in this recall event:
- Lidocaine gel 2%, RX, plastic dropper (D-0397-2019)
- Hydroxyprogesterone liquid, 250mg/ml, RX, glass vial (D-0396-2019)
- Glutathione liquid, 200mg/ml, Rx (D-0407-2019)
- MIC B vitamin liquid 25/50/50/1/1/1mg/ml RX glass vial (D-0399-2019)
- Lidocaine gel 1%, RX, plastic dropper (D-0408-2019)
- HCG liquid, 1000u/ml, RX, glass vial, various (D-0395-2019)
- Testosteron Cypionate liquid 200mg/ml, RX, glass vial (D-0401-2019)
- Cyclosporin liquid 2%, Rx, plastic dropper bottle, dry eye (D-0392-2019)
- Cyclosporin liquid 0.2%, Rx, plastic dropper bottle (D-0405-2019)
- Cyclosporin liquid 0.05%, Rx, plastic dropper bottle (D-0406-2019)
- Vitamin B12 liquid 1000mcg/ml, RX, glass vial (D-0402-2019)
- Glutathione liquid, 100mg/ml (D-0394-2019)
- Lidocaine/Epinepherine liquid 1%/ 1:1000, RX, glass vial These include injectable medications, sterile solutions, eye drops, and eye ointments (D-0398-2019)
- Epinephrine liquid 1:1000, RX, glass vial (D-0393-2019)
- Cyclosporin liquid 1%, Rx, plastic dropper bottle (D-0403-2019)
- Cyclosporin liquid 0.5%, Rx, plastic dropper bottle (D-0404-2019)
- Methocarbamol liquid 100mg/ml, RX, glass vial (D-0400-2019)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.